Kevin Quinlan has been named CFO of Anika Therapeutics (Woburn, Massachusetts). Quinlan joins the company from Boston Biomedica, where he most recently served as president of its BBI Diagnostics division. Anika Therapeutics develops hyaluronic acid-based therapeutic products and devices intended to promote the repair, protection and healing of bone, cartilage and soft tissue.
Cancer-based molecular diagnostics firm CombiMatrix Molecular Diagnostics (CMD; Irvine, California), a wholly-owned subsidiary of CombiMatrix, an Acacia Research company, appointed Matthew Moore, PhD, director of research and development; Robert Embree, director of laboratory operations; and John Besser, CFO. Moore, most recently of US Labs, joined CMD in June. Embree served as managing director of global immunohistochemistry and virtual image analysis for US Labs prior to joining CMD. Besser most recently served as controller for Quest Diagnostics' Nichols Institute. CMD is a cancer-based molecular diagnostics company.
Tom McLaughlin has been promoted to the position of vice president-North America imaging sales, for E-Z-EM (Lake Success, New York). McLaughlin has served the company in a series of positions since 1989, beginning as a territory sales manager for Philadelphia and later as Eastern District sales manager. Most recently, he served as senior director-North America sales. E-Z-EM manufactures contrast agents for gastrointestinal radiology. The company recently introduced VoLumen, a low-density barium sulfate suspension for use as an oral contrast in multidetector CT and PET/CT studies.
Steven Durnil has been named president and CEO of Fischer Imaging (Denver), succeeding Harris Ravine, who resigned from the company as an officer and member of the board of directors effective immediately. Ravine will continue to serve in a consulting capacity. Durnil previously was Fischer's chief operating officer. He joined the company as vice president of manufacturing and supply chain in July 2004. Previously he was with Hitachi Business Consulting as a senior manager in high-technology supply chain management. Durnil will retain his COO responsibilities. The company said that it is in the process of transitioning its business in connection with the previously announced decision to sell the intellectual property associated with its mammography business to Hologic. Fischer Imaging manufactures imaging systems for the screening and diagnosis of disease, particularly the diagnosis and screening of breast cancer. The company also produces equipment designed for emergency, radiology, surgical and certain cardiovascular needs.
Bret Jorgensen has been appointed president and CEO of InSight Health Services Holdings (Lake Forest, California). He also will be elected to the company's board of directors. Michael Cannizzaro, president and CEO of InSight since August 2004, will remain chairman of the board. Jorgensen previously was CEO of AdvoLife, a provider of home-based long-term eldercare services. He was a co-founder of TheraTx, a diversified healthcare services company. InSight Health Services provides diagnostic imaging and information, treatment and related management services. It serves managed care entities, hospitals and other contractual customers in 35 states.
Jonah Aburrow-Jones has been named to the newly created position of product and accounts manager for Medicsight plc (London). He has more than 12 years of product management and sales experience, most recently serving as senior product line manager for the Voxar Product Group of Barco. Prior to Barco, he was product manager - International for E-Z-EM, an international manufacturer of contrast agents for gastrointestinal radiology. Medicsight is a software development business focused on the medical imaging market. The company is using its core technology to develop automatic detection and analytical tools for clinicians to improve their ability to diagnose and treat disease, initially focusing on three key clinical areas — lung cancer, colon cancer and coronary heart disease.
PBI Technology (Seattle), a wholly owned subsidiary of Pacific Biometrics (PBME), has formed a new leadership team. Dr. Mario Ehlers, chief medical officer of PBME, took the lead as PBI Technology's president, chief operating officer and a director as of June 1. Ehlers is a physician-scientist with 11 years of experience in academic research and seven years in the biopharmaceutical industry. Ronald Helm will serve as chairman of the board. Helm currently also is chairman and CEO of PBME, serving in those capacities since August 2002. Kenneth Waters will serve as director of strategic planning and as vice chairman of the board. Waters also is director of strategic planning for PBME, serving in that post since September 2002. PBI Technology was created in March 2004 to commercialize four molecular diagnostic technologies formerly held by PBME and recently transferred to the subsidiary: the Osteopatch, a non-invasive device for osteoporosis testing; the SalivaSac, a non-invasive device for measuring glucose levels; LIDA, a platform technology for DNA amplification; and Cell Viability, for cell identification.
Mark Mindell has been appointed vice president, human resources, at Toshiba America Medical Systems (Tustin, California). He previously held similar posts with Philips Medical Systems, Invensys and Entex/Siemens Business Systems. Toshiba America Medical Systems is a provider of diagnostic medical imaging systems.